Table 2 Time to viral rebound after discontinuation of ART and peak viral load at rebound.

From: Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1

 

PTID

Time to viral reboud (weeks)

Peak VL at rebound

Placebo

39472

No rebound

<150

43068

No rebound

<150

43268

3

1500

42368

3

1300

39950

2

13,000

38200

No rebound

<150

HIV Clade B/C

42870

4

650

41919

No rebound

<150

42814

3

3700

43633

4

1800

41522

4

250

41672

3

2800

Back to article page